185 related articles for article (PubMed ID: 26617729)
1. Activation of unfolded protein response protects osteosarcoma cells from cisplatin-induced apoptosis through NF-κB pathway.
Yan M; Ni J; Song D; Ding M; Huang J
Int J Clin Exp Pathol; 2015; 8(9):10204-15. PubMed ID: 26617729
[TBL] [Abstract][Full Text] [Related]
2. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics.
Gaddameedhi S; Chatterjee S
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S61-6. PubMed ID: 20009298
[TBL] [Abstract][Full Text] [Related]
3. Green tea polyphenols-induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with downregulation of nuclear factor-kappaB.
Hafeez BB; Ahmed S; Wang N; Gupta S; Zhang A; Haqqi TM
Toxicol Appl Pharmacol; 2006 Oct; 216(1):11-9. PubMed ID: 16797629
[TBL] [Abstract][Full Text] [Related]
4. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
5. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
[TBL] [Abstract][Full Text] [Related]
7. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
8. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling.
Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY
Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells.
Kim SB; Kim JS; Lee JH; Yoon WJ; Lee DS; Ko MS; Kwon BS; Choi DH; Cho HR; Lee BJ; Chung DK; Lee HW; Park JW
FEBS Lett; 2006 Jan; 580(1):311-8. PubMed ID: 16376337
[TBL] [Abstract][Full Text] [Related]
10. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
11. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
[TBL] [Abstract][Full Text] [Related]
12. [Thrichosanthin enhances cisplatin-induced laryngocarcinoma apoptosis through inhibiting transcription factor nuclear factor κB].
Zhang D; Lu LM; Chen B; Li Q; Zhou J; Tao L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Apr; 48(4):322-8. PubMed ID: 23886095
[TBL] [Abstract][Full Text] [Related]
13. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
14. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
Ma J; Huang H; Han Z; Zhu C; Yue B
Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor-κB activity enhanced chemosensitivity to cisplatin in human lung adeno-carcinoma A549 cells under chemical hypoxia conditions.
Li F; Huang L; Su XL; Gu QH; Hu CP
Chin Med J (Engl); 2013; 126(17):3276-82. PubMed ID: 24033949
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic gene TRIM10 confers resistance to cisplatin in osteosarcoma cells and activates the NF-κB signaling pathway.
Xi X; Bao Y; Zhou Y; Chen Y; Zhong X; Liao J; Zhou J; Xu S; Cao Z; Hu K; Hu Y; He X; Zhou L; Lin H; Wu Q
Cell Biol Int; 2021 Jan; 45(1):74-82. PubMed ID: 32997424
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation.
Campbell KJ; Witty JM; Rocha S; Perkins ND
Cancer Res; 2006 Jan; 66(2):929-35. PubMed ID: 16424027
[TBL] [Abstract][Full Text] [Related]
19. [Effect of C23 down-regulation on proliferation inhibition and apoptosis induced by cisplatin in human osteosarcoma SaOS-2 cells].
Wu B; Wang W; Li Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):32-7. PubMed ID: 22349377
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
